Skip to main content

Table 4 Risk of poor outcome in IS subtypes per unit increase in acute log HOMA-IR

From: Homeostasis model assessment of insulin resistance and outcome of ischemic stroke in non-diabetic patients - a prospective observational study

 

n

Crude OR

3 months

 Large vessel disease

37

0.73 (0.19–2.85)

 Small vessel disease

85

0.31 (0.07–1.30)

 Cardioembolic stroke

74

1.81 (0.85–3.85)

 Cryptogenic stroke

119

3.65 (1.53–8.72)**

2 years

 Large vessel disease

40

0.39 (0.10–1.47)

 Small vessel disease

90

0.37 (0.11–1.20)

 Cardioembolic stroke

74

1.29 (0.61–2.73)

 Cryptogenic stroke

122

4.77 (1.93–11.8)***

7 years Deaths (mRS 6) included

 Large vessel disease

30

2.36 (0.59–9.45)

 Small vessel disease

61

0.92 (0.30–2.77)

 Cardioembolic stroke

51

1.55 (0.70–3.42)

 Cryptogenic stroke

93

2.09 (0.90–4.87)

7 years Deaths (mRS 6) excluded

 Large vessel disease

22

0.76 (0.14–4.03)

 Small vessel disease

59

1.16 (0.36–3.77)

 Cardioembolic stroke

35

1.25 (0.42–3.77)

 Cryptogenic stroke

84

2.30 (0.74–7.16)

  1. Odds ratios (ORs) and 95% confidence intervals (CIs) of having a poor outcome (mRS ≥3) for the main etiologies of IS (according to TOAST) at different time points per unit increase in acute log-HOMA-IR. p = 0.08, **p < 0.01, ***p < 0.001